Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Knapp

Showing results (211-220 of 263) with videos related to

Pageof 27
Sort By:
The Journal of Clinical Psychiatry|February 5, 2009
Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE)Keith G Rasmussen, Martina Mueller, Teresa A Rummans, et al.
The Journal of ECT|December 20, 2007
Data management and design issues in an unmasked randomized trial of electroconvulsive therapy for relapse prevention of severe depression: the consortium for research in electroconvulsive therapy trialKeith G Rasmussen, Rebecca G Knapp, Melanie M Biggs, et al.
Psychiatric Services (Washington, D.C.)|September 9, 2005
Patients' reports of traumatic or harmful experiences within the psychiatric settingB Christopher Frueh, Rebecca G Knapp, Karen J Cusack, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Clinical development plan: DHEA analog 8354G J Kelloff, J A Crowell, C W Boone, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Clinical development plan: N-(4-hydroxyphenyl)retinamideG J Kelloff, J A Crowell, C W Boone, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Clinical development plan: aspirinG J Kelloff, J A Crowell, C W Boone, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Clinical development plan: beta-carotene and other carotenoidsG J Kelloff, J A Crowell, C W Boone, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Clinical development plan: 18beta-glycyrrhetinic acidG J Kelloff, J A Crowell, C W Boone, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Clinical development plan: sulindacG J Kelloff, J A Crowell, C W Boone, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Clinical development plan: vitamin D3 and analogsG J Kelloff, J A Crowell, C W Boone, et al.
Pageof 27

Showing results (211-220 of 263) with videos related to

Sort By:
Pageof 27
The Journal of Clinical Psychiatry|February 5, 2009
Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE)Keith G Rasmussen, Martina Mueller, Teresa A Rummans, et al.
The Journal of ECT|December 20, 2007
Data management and design issues in an unmasked randomized trial of electroconvulsive therapy for relapse prevention of severe depression: the consortium for research in electroconvulsive therapy trialKeith G Rasmussen, Rebecca G Knapp, Melanie M Biggs, et al.
Psychiatric Services (Washington, D.C.)|September 9, 2005
Patients' reports of traumatic or harmful experiences within the psychiatric settingB Christopher Frueh, Rebecca G Knapp, Karen J Cusack, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Clinical development plan: DHEA analog 8354G J Kelloff, J A Crowell, C W Boone, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Clinical development plan: N-(4-hydroxyphenyl)retinamideG J Kelloff, J A Crowell, C W Boone, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Clinical development plan: aspirinG J Kelloff, J A Crowell, C W Boone, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Clinical development plan: beta-carotene and other carotenoidsG J Kelloff, J A Crowell, C W Boone, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Clinical development plan: 18beta-glycyrrhetinic acidG J Kelloff, J A Crowell, C W Boone, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Clinical development plan: sulindacG J Kelloff, J A Crowell, C W Boone, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
Clinical development plan: vitamin D3 and analogsG J Kelloff, J A Crowell, C W Boone, et al.
Pageof 27